Ligand Pharmaceuticals, Inc. (LGND)
202.91
-8.57
(-4.05%)
USD |
NASDAQ |
Mar 13, 16:00
202.73
-0.18
(-0.09%)
After-Hours: 20:00
Ligand Pharmaceuticals Market Cap : 4.046B for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.512B |
| ADMA Biologics, Inc. | 3.608B |
| Merck & Co., Inc. | 285.83B |
| Globus Medical, Inc. | 11.47B |
| Establishment Labs Holdings, Inc. | 1.857B |
Market Cap Related Metrics
| PE Ratio | 34.78 |
| PS Ratio | 15.30 |
| Price to Book Value | 3.978 |
| Price to Free Cash Flow | 107.85 |
| Price | 202.91 |
| Earnings Yield | 2.88% |
| Operating PE Ratio | 86.93 |
| Normalized PE Ratio | 65.77 |